278 related articles for article (PubMed ID: 12016479)
1. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.
Berber E; Flesher N; Siperstein AE
World J Surg; 2002 Aug; 26(8):985-90. PubMed ID: 12016479
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
Mazzaglia PJ; Berber E; Milas M; Siperstein AE
Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
Gillams A; Cassoni A; Conway G; Lees W
Abdom Imaging; 2005; 30(4):435-41. PubMed ID: 15759207
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
5. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
6. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation: a novel primary and adjunctive ablative technique for hepatic malignancies.
Rose DM; Allegra DP; Bostick PJ; Foshag LJ; Bilchik AJ
Am Surg; 1999 Nov; 65(11):1009-14. PubMed ID: 10551746
[TBL] [Abstract][Full Text] [Related]
10. [Radiofrequency ablation of colorectal liver metastases].
Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
[TBL] [Abstract][Full Text] [Related]
12. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study.
Berber E; Pelley R; Siperstein AE
J Clin Oncol; 2005 Mar; 23(7):1358-64. PubMed ID: 15684312
[TBL] [Abstract][Full Text] [Related]
13. Clinical short-term results of radiofrequency ablation in patients with liver metastases from colorectal cancer.
Basdanis G; Michalopoulos A; Papadopoulos V; Tzeveleki I; Efthimiadis Ch; Kosmidis Ch; Mekras D; Harlaftis N
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s187-9. PubMed ID: 15655617
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency thermal ablation (RFA) of liver tumors: percutaneous and open surgical approaches.
Crucitti A; Danza FM; Antinori A; Vincenzo A; Pirulli PG; Bock E; Magistrelli P
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):191-5. PubMed ID: 16767930
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
18. Experience with more than 500 minimally invasive hepatic procedures.
Buell JF; Thomas MT; Rudich S; Marvin M; Nagubandi R; Ravindra KV; Brock G; McMasters KM
Ann Surg; 2008 Sep; 248(3):475-86. PubMed ID: 18791368
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up.
Akyildiz HY; Mitchell J; Milas M; Siperstein A; Berber E
Surgery; 2010 Dec; 148(6):1288-93; discussion 1293. PubMed ID: 21134563
[TBL] [Abstract][Full Text] [Related]
20. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned.
Choy PY; Koea J; McCall J; Holden A; Osbourne M
N Z Med J; 2002 Aug; 115(1159):U128. PubMed ID: 12362172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
